-
Story
A Journey of Compassion: From Pharmacy to Oncology Sales -
Story
Remembering men’s health this National Veterans and Military Families Month -
Media Release
Novartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers
-
Media Release
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer